Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of SR1375 in Healthy Volunteers
NCT05026008Phase 1Completed
- Sponsor
- Shanghai SIMRD Biotechnology Co., Ltd.
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pneumonia and diabetic kidney disease (DKD) comparing SR1375 Capsule with Matching Placebo (2 arms). Primary endpoint: Adverse Event. Started Sep 2021; status: completed.
02
Drugs
SR1375
03
Conditions
pneumoniadiabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT05026008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05026008.